Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Arya Health Secures $18.2M Series A to Power the Next Generation of AI Agents for Post-Acute Care Administration
Arya Health, an AI company helping home health and post-acute care providers automate scheduling, compliance, and other administrative operations, announced today its $18.2 million Series A funding. The round was led by ACME Capital, with participation from Ridge Ventures, Twelve Below, executives from OpenAI, and leading post-acute care providers, bringing Arya’s total funding to $25 million.
Post-acute care providers, including home healthcare agencies, hospice providers, and long-term care facilities, are facing unprecedented strain. Rapid regulatory changes, caregiver shortages, and escalating wage pressures are pushing an already margin-constrained industry to the brink. Meanwhile, heavy private equity investment and consolidation call for a renewed focus on operational excellence and thinking beyond the traditional “people-heavy” approach to post-acute care administration.
Arya is building a new AI-native “system of action” that sits alongside the Electronic Medical Record (EMR) to automate the heavy administrative load that burdens front office teams, slows growth, and diverts resources from patient care and caregiver support.
“Post-acute care organizations spend roughly 25 cents of every dollar on non-clinical tasks,” said Kunal Sarda, Co-Founder and CEO at Arya Health…
Full release here, originally announced October 29th, 2025.
Popai Health Raises $11M to Transform Care Coordination with Voice AI
Popai Health, the Patient Conversation Intelligence company that transforms patient conversations into action, announced today that it has raised $11 million in funding led by Team8, NEA, and additional strategic investors. The funding will strengthen Popai’s go-to-market efforts, drive faster adoption across health systems, medical groups, health plans, and ACOs, and enable the team to scale with increasing market demand.
Popai revolutionizes care coordination by leveraging Voice AI to eliminate healthcare’s largest patient engagement blind spot – the 65% of patient interactions that happen during phone calls. Traditional care coordination systems capture only a fraction of the information exchanged during 15M daily patient calls, limiting visibility into key clinical, operational, and social insights. With Popai, care coordination calls become one of healthcare organizations’ most valuable strategic assets, optimizing how care coordination teams operate and deliver patient care.
“After deep evaluation of voice capabilities across our healthcare portfolio, we view Popai’s solution as incredibly differentiated, with a use case that extends beyond pure administration in enabling automated workflow actions for healthcare organizations,” said Blake Wu, Partner at NEA. “Popai’s platform is designed to not only meet the needs of today’s risk-bearing healthcare organizations but also to adapt and grow with them. We believe this makes Popai a strong strategic partner both now and into the future, and we are thrilled to support the company’s seed financing and mission to transform care through Voice AI.”
Popai’s Patient Conversation Intelligence platform, which is already in use by Essen Healthcare and Clover Health among others, captures and analyzes patient phone conversations using healthcare-specific AI trained on medical terminology and clinical context…
Full release here, originally announced November 3rd, 2025.
Hippocratic AI Raises $126 Million in Series C at $3.5 Billion Valuation Led by Avenir Growth to Expand Clinically Safe Generative AI Agents Across Healthcare
Hippocratic AI, the global leader in safety-focused generative AI healthcare agents, today announced the close of its Series C financing, raising $126 million at a $3.5 billion valuation and bringing its total funding to $404 million.
The funding was led by Avenir Growth, a leader in supporting category defining companies in generative AI, with participation from new and existing investors, including CapitalG (Google’s growth fund), General Catalyst, Andreessen Horowitz (a16z), Kleiner Perkins, Premji Invest, Universal Health Services (UHS), Cincinnati Children’s Hospital Medical Center, WellSpan Health, John Doerr, Rick Klausner, and others.
In just 15 months since commercialization, the company has established partnerships with over 50 large health systems, payors, and pharma clients in 6 countries, built over 1000 clinical use cases, and completed over 115 million clinical patient interactions with no safety issues. Adoption is accelerating as healthcare organizations turn to scalable, safe generative AI agents to enable healthcare abundance.
“At Avenir, we focus on investing in category leaders,” said Andrew Sugrue, Co-Founder of Avenir Growth…
Full release here, originally announced November 3rd, 2025.
No comments:
Post a Comment